No association between GB virus C infection and disease progression in HIV-2-infected patients from the French ANRS HIV-2 cohort

被引：3

作者：

Descamps, D ^{[1
]}

Damond, F

Benard, A

Matheron, S

Campa, P

Taieb, A

Yahyaoui, R

Chene, G

Brun-Vezinet, F

机构：

[1] Hop Bichat Claude Bernard, F-75877 Paris 18, France

[2] INSERM U593, Bordeaux, France

[3] Hop St Antoine, F-75571 Paris, France

来源：

AIDS | 2006年 / 20卷 / 07期

关键词：

D O I：

10.1097/01.aids.0000222086.29164.6e

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Out of 183 HIV-2-infected patients tested in the ANRS CO8 HIV-2 cohort, 69 were exposed to GB virus C (GBV-C), yielding a prevalence of 38% (95% CI 30.7, 45.2). There was no significant difference between the CD4 cell count and HIV-2-RNA plasma viral load in patients exposed and not exposed to GBV-C. After adjusting for age and CD4 cell count, co-infection with GBV-C was not associated with clinical progression (hazard ratio 0.78; 95% CI 0.24-2.56, 16 clinical events).

引用

页码：1076 / 1079

页数：4

共 50 条

[21] Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians
Jobarteh, Modou
Malfroy, Marine
Peterson, Ingrid
Jeng, Adam
Sarge-Njie, Ramu
Alabi, Abraham
Peterson, Kevin
Cotten, Matt
Hall, Andrew
Rowland-Jones, Sarah
Whittle, Hilton
Tedder, Richard
Jaye, Assan
Mendy, Maimuna
VIROLOGY JOURNAL, 2010, 7
[22] Mother-to-Child Transmission of HIV-2 Infection from 1986 to 2007 in the ANRS French Perinatal Cohort EPF-CO1
Burgard, M.
Jasseron, C.
Matheron, S.
Damond, F.
Hamrene, K.
Blanche, S.
Faye, A.
Rouzioux, C.
Warszawski, J.
Mandelbrot, L.
CLINICAL INFECTIOUS DISEASES, 2010, 51 (07) : 833 - 843
[23] Cohort Profile Update: The Bissau HIV Cohort-a Cohort of HIV-1, HIV-2 and Co-infected Patients
Dutschke, Alexander
Jespersen, Sanne
Medina, Candida
Nanque, Joao Paulo
Rodrigues, Amabelia
Wejse, Christian
Honge, Bo Langhoff
Jensen, Mads Mose
Bissau HIV Cohort Study Grp
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2023, 52 (04) : E232 - E240
[24] Transfusion Transmission of GB Virus Type C (HGV) In a Cohort of HIV Infected Patients
Vahidnia, Farnaz
Petersen, Maya
Rutherford, George
Busch, Michael
Assmann, Susan
Stapleton, Jack
Custer, Brian
BLOOD, 2010, 116 (21) : 1368 - 1368
[25] First-line Raltegravir/Emtricitabine/Tenofovir Combination in Human Immunodeficiency Virus Type 2 (HIV-2) Infection: A Phase 2, Noncomparative Trial (ANRS 159 HIV-2)
Matheron, Sophie
Descamps, Diane
Gallien, Sebastien
Besseghir, Amel
Sellier, Pierre
Blum, Laurent
Mortier, Emmanuel
Charpentier, Charlotte
Tubiana, Roland
Damond, Florence
Peytavin, Gilles
Ponscarme, Diane
Collin, Fideline
Brun-Vezinet, Francoise
Chene, Genevieve
CLINICAL INFECTIOUS DISEASES, 2018, 67 (08) : 1161 - 1167
[26] Persistent GB virus C infection is associated with decreased HIV-1 disease progression in the Amsterdam Cohort study
George, SL
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (12): : 2156 - 2157
[27] Hepatitis C virus infection in a cohort of 1161 HIV-infected patients
Muñoz-Pérez, MA
Rodriguez-Pichardo, A
Camacho, F
Colmenero, MA
INTERNATIONAL JOURNAL OF STD & AIDS, 1999, 10 (01) : 69 - 70
[28] Characteristics and disease progression among people living with HIV-2 infection in Germany
Koppe, Uwe
Berzow, Dirk
Sailer, Andrea
Kollan, Christian
Bremer, Viviane
Gunsenheimer-Bartmeyer, Barbara
Schmidt, Daniel
HIV MEDICINE, 2023, 24 : 16 - 16
[29] GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study
Van der Bij, AK
Kloosterboer, N
Prins, M
Boeser-Nunnink, B
Geskus, RB
Lange, JMA
Coutinho, RA
Schuitemaker, H
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (05): : 678 - 685
[30] Clearance of GB virus C during highly active antiretroviral therapy and course of HIV disease progression in HIV-infected patients with hemophilia
Toyoda, H
Honda, T
Katano, Y
Goto, H
Takamatsu, J
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2005, 24 (09) : 645 - 646

← 1 2 3 4 5 →